Cargando…
Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome
PURPOSE: 25% of all lung cancer cases are neuroendocrine (NELC) including typical (TC) and atypical carcinoid (AC), large-cell neuroendocrine (LCNEC) and small cell lung cancer (SCLC). Prognostic and predictive biomarkers are lacking. EXPERIMENTAL DESIGN: Sixty patients were used for nCounter mRNA e...
Autores principales: | Henry Walter, Robert Fred, Mairinger, Fabian Dominik, Werner, Robert, Vollbrecht, Claudia, Hager, Thomas, Schmid, Kurt Werner, Wohlschlaeger, Jeremias, Christoph, Daniel Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991445/ https://www.ncbi.nlm.nih.gov/pubmed/27064343 http://dx.doi.org/10.18632/oncotarget.7737 |
Ejemplares similares
-
ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology
por: Walter, Robert Fred Henry, et al.
Publicado: (2016) -
Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis
por: Walter, Robert Fred Henry, et al.
Publicado: (2015) -
microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma
por: Walter, Robert Fred Henry, et al.
Publicado: (2016) -
Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group
por: Vollbrecht, Claudia, et al.
Publicado: (2015) -
Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma
por: Mairinger, Fabian Dominik, et al.
Publicado: (2017)